Out of stockOut of stock
Out of stock25mg GLP-3 RT research peptide for scientific study, contains GLP-1, GIP, glucagon.
  • 25mg GLP-3 RT research peptide for scientific study, contains GLP-1, GIP, glucagon.

GLP-3 RT is a novel tri-agonist peptide targeting GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. This synthetic peptide represents an advanced class of metabolic research compounds designed for investigating multi-receptor pharmacology and integrated metabolic pathway modulation.

Mechanism of Action

GLP-3 RT demonstrates balanced agonism across three incretin and glucagon receptor systems:

  • GIP Receptor: Modulates insulin secretion and lipid metabolism
  • GLP-1 Receptor: Regulates glucose homeostasis and satiety signaling
  • Glucagon Receptor: Influences energy expenditure and hepatic glucose output

This tri-agonist architecture enables comprehensive investigation of synergistic metabolic pathway interactions in controlled experimental settings.

Research Applications

  • Metabolic disease modeling and pathway analysis
  • Incretin receptor pharmacology studies
  • Multi-target therapeutic strategy development
  • Comparative efficacy studies with mono- or dual-agonist peptides
  • Receptor binding and signaling cascade investigations
  • Pharmacokinetic and pharmacodynamic profiling

Quality Specifications

  • Synthesized via solid-phase peptide synthesis (SPPS)
  • Purity confirmed by HPLC and mass spectrometry
  • Certificate of Analysis (CoA) included with each batch
  • Endotoxin levels: <1.0 EU/mg
  • Sterility tested per USP guidelines
Strength

25mg

Reviews

There are no reviews yet

Add a review
GLP-3 RT 25mg GLP-3 RT 25mg
Overall rating*
0/5
* Rating is required
Was the product of quality?*
0/5
* Rating is required
How was the shipping speed?
0/5
* Rating is required
Was it good value for the price?
0/5
* Rating is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please tick the checkbox to proceed
* Please confirm that you are not a robot
SKU: GLP-3-RT-25MG
GLP-3 RT 25mg

GLP-3 RT 25mg

$230.99

Retatrutide is a novel tri-agonist peptide targeting GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. This synthetic peptide represents an advanced class of metabolic research compounds designed for investigating multi-receptor pharmacology and integrated metabolic pathway modulation.

Buy Now
Quantity

Testing & Quality Assurance

Trust starts with transparency. Premier Bio Labs subjects every batch to comprehensive third-party testing before release, ensuring the materials powering your research meet pharmaceutical-grade standards.

Complete Batch Testing

Each product includes a Certificate of Analysis (COA) with verifiable data from independent laboratories.

COA Testing Parameters

  • Identity Verification – HPLC and Mass Spectrometry confirm molecular structure
  • Purity Analysis – HPLC quantification, typically ≥98%
  • Concentration Accuracy – Verified dosing levels
  • Molecular Weight – Mass spectrometry confirmation
  • Endotoxin Screening – LAL assay, <1.0 EU/mg
  • pH Testing – Solution stability validation
  • Sterility – Microbial contamination screening
  • Heavy Metals – Lead, mercury, cadmium analysis
  • Residual Solvents – Organic solvent detection
  • Moisture Content – Karl Fischer titration
  • Physical Inspection – Color, clarity, appearance
  • Traceability – Batch numbers, test dates, storage specs

All COAs include methodology, acceptance criteria, actual results, and QC team verification.

Legal Disclaimer:

The products offered by Premier Bio Labs are intended strictly for laboratory research purposes only and are sold exclusively to qualified professionals, institutions, and entities. These products are not for human consumption, veterinary use, or any application involving living organisms, including but not limited to diagnostic, therapeutic, or recreational purposes.
 

Prohibited Uses:

These products are not to be used as active pharmaceutical ingredients (APIs)for compounding or manufacturing drugs for human or veterinary use. It is strictly prohibited to administer these products to humans or animals under any circumstances. Premier Bio Labs does not condone, endorse, or permit the use of its products for the development, testing, or production of controlled substances or illegal compounds.

Regulatory Compliance:

Premier Bio Labs makes no claims, representations, or warranties that its products are approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency for any specific purpose. The statements regarding these products have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
 

Liability Statement:

The purchaser assumes full responsibility for the safe handling, storage, transport, and use of any product obtained from Premier Bio Labs. Under no circumstances shall Premier Bio Labs, its owners, employees, or affiliates be held liable for any damages, injuries, or losses — direct or indirect — resulting from misuse, mishandling, or unauthorized application of its products.
 
Premier Bio Labs reserves the right to refuse sales to any individual or entity suspected of misuse, illegal activity, or non-compliance with these terms.
If you are uncertain about the safe and lawful use of these products, consult a qualified professional with expertise in laboratory research before purchase or use.
 
By completing a purchase with Premier Bio Labs, you acknowledge that you have read, understood, and agreed to this disclaimer in full.

GLP-3 RT is a novel tri-agonist peptide targeting GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. This synthetic peptide represents an advanced class of metabolic research compounds designed for investigating multi-receptor pharmacology and integrated metabolic pathway modulation.

Mechanism of Action

GLP-3 RT demonstrates balanced agonism across three incretin and glucagon receptor systems:

  • GIP Receptor: Modulates insulin secretion and lipid metabolism
  • GLP-1 Receptor: Regulates glucose homeostasis and satiety signaling
  • Glucagon Receptor: Influences energy expenditure and hepatic glucose output

This tri-agonist architecture enables comprehensive investigation of synergistic metabolic pathway interactions in controlled experimental settings.

Research Applications

  • Metabolic disease modeling and pathway analysis
  • Incretin receptor pharmacology studies
  • Multi-target therapeutic strategy development
  • Comparative efficacy studies with mono- or dual-agonist peptides
  • Receptor binding and signaling cascade investigations
  • Pharmacokinetic and pharmacodynamic profiling

Quality Specifications

  • Synthesized via solid-phase peptide synthesis (SPPS)
  • Purity confirmed by HPLC and mass spectrometry
  • Certificate of Analysis (CoA) included with each batch
  • Endotoxin levels: <1.0 EU/mg
  • Sterility tested per USP guidelines
Strength

25mg

Reviews

There are no reviews yet

Add a review
GLP-3 RT 25mg GLP-3 RT 25mg
Overall rating*
0/5
* Rating is required
Was the product of quality?*
0/5
* Rating is required
How was the shipping speed?
0/5
* Rating is required
Was it good value for the price?
0/5
* Rating is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please tick the checkbox to proceed
* Please confirm that you are not a robot
Shopping Cart
Scroll to Top